搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella typhimurium NADH pyrophosphatase (nudC) CSB-YP864726SXB
CSB-EP864726SXB
CSB-BP864726SXB
CSB-MP864726SXB
CSB-EP864726SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus thermoleovorans ATP synthase subunit beta (atpD) CSB-YP864727GEAE
CSB-EP864727GEAE
CSB-BP864727GEAE
CSB-MP864727GEAE
CSB-EP864727GEAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein phosphatase CheZ (cheZ) CSB-YP864728VFE
CSB-EP864728VFE
CSB-BP864728VFE
CSB-MP864728VFE
CSB-EP864728VFE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 3-hexulose-6-phosphate isomerase (rmpB) CSB-YP864729MDAF
CSB-EP864729MDAF
CSB-BP864729MDAF
CSB-MP864729MDAF
CSB-EP864729MDAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative N-acetylmannosaminyltransferase (tagA) CSB-YP864730FKZ
CSB-EP864730FKZ
CSB-BP864730FKZ
CSB-MP864730FKZ
CSB-EP864730FKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Na (+)-translocating NADH-quinone reductase subunit F (nqrF) CSB-YP864731PTO
CSB-EP864731PTO
CSB-BP864731PTO
CSB-MP864731PTO
CSB-EP864731PTO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chaperone protein DnaK (dnaK), partial CSB-YP864732BLV
CSB-EP864732BLV
CSB-BP864732BLV
CSB-MP864732BLV
CSB-EP864732BLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha, chloroplastic (CAC3), partial CSB-YP864733DOA
CSB-EP864733DOA
CSB-BP864733DOA
CSB-MP864733DOA
CSB-EP864733DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lilium longiflorum Histone H2A.2 (gH2A) CSB-YP864734LFR
CSB-EP864734LFR
CSB-BP864734LFR
CSB-MP864734LFR
CSB-EP864734LFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCB), partial CSB-YP864735DOA
CSB-EP864735DOA
CSB-BP864735DOA
CSB-MP864735DOA
CSB-EP864735DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana LAG1 longevity assurance homolog 1 (LAG1), partial CSB-YP864736DOA1
CSB-EP864736DOA1
CSB-BP864736DOA1
CSB-MP864736DOA1
CSB-EP864736DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Cyclin-B2-3 (CYCB2-3) CSB-YP864737DOA
CSB-EP864737DOA
CSB-BP864737DOA
CSB-MP864737DOA
CSB-EP864737DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Camellia sinensis S-adenosylmethionine synthase (SAM) CSB-YP864738CBP
CSB-EP864738CBP
CSB-BP864738CBP
CSB-MP864738CBP
CSB-EP864738CBP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UDP-galactose/UDP-glucose transporter 4 (UTR4), partial CSB-YP864739DOA
CSB-EP864739DOA
CSB-BP864739DOA
CSB-MP864739DOA
CSB-EP864739DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Germin-like protein subfamily 1 member 8 (GLP9) CSB-YP864740DOA
CSB-EP864740DOA
CSB-BP864740DOA
CSB-MP864740DOA
CSB-EP864740DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays FACT complex subunit SSRP1 (SSRP1), partial CSB-YP864741ZAX
CSB-EP864741ZAX
CSB-BP864741ZAX
CSB-MP864741ZAX
CSB-EP864741ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Digitalis lanata Peptidyl-prolyl cis-trans isomerase Pin1 (PARV12.8) CSB-YP864742DKO
CSB-EP864742DKO
CSB-BP864742DKO
CSB-MP864742DKO
CSB-EP864742DKO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Pentatricopeptide repeat-containing protein At5g14770, mitochondrial (At5g14770), partial CSB-YP864743DOA
CSB-EP864743DOA
CSB-BP864743DOA
CSB-MP864743DOA
CSB-EP864743DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Protein-ribulosamine 3-kinase, chloroplastic (At3g61080) CSB-YP864744DOA
CSB-EP864744DOA
CSB-BP864744DOA
CSB-MP864744DOA
CSB-EP864744DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Acyl-[acyl-carrier-protein] desaturase 3, chloroplastic (S-ACP-DES3) CSB-YP864745DOA
CSB-EP864745DOA
CSB-BP864745DOA
CSB-MP864745DOA
CSB-EP864745DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>